150 related articles for article (PubMed ID: 26785809)
1. Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM.
Cho S; Park I; Kim H; Jeong MS; Lim M; Lee ES; Kim JH; Kim S; Hong HJ
MAbs; 2016; 8(2):414-25. PubMed ID: 26785809
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma.
Wolterink S; Moldenhauer G; Fogel M; Kiefel H; Pfeifer M; Lüttgau S; Gouveia R; Costa J; Endell J; Moebius U; Altevogt P
Cancer Res; 2010 Mar; 70(6):2504-15. PubMed ID: 20215505
[TBL] [Abstract][Full Text] [Related]
3. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
[TBL] [Abstract][Full Text] [Related]
4. Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.
Cho S; Lee TS; Song IH; Kim AR; Lee YJ; Kim H; Hwang H; Jeong MS; Kang SG; Hong HJ
PLoS One; 2017; 12(2):e0170078. PubMed ID: 28166242
[TBL] [Abstract][Full Text] [Related]
5. Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods.
Chae H; Cho S; Jeong M; Kwon K; Choi D; Lee J; Nam W; Hong J; Lee J; Yoon S; Hong H
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206616
[TBL] [Abstract][Full Text] [Related]
6. Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT.
Doberstein K; Harter PN; Haberkorn U; Bretz NP; Arnold B; Carretero R; Moldenhauer G; Mittelbronn M; Altevogt P
Int J Cancer; 2015 Mar; 136(5):E326-39. PubMed ID: 25230579
[TBL] [Abstract][Full Text] [Related]
7. A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model.
Lee ES; Jeong MS; Singh R; Jung J; Yoon H; Min JK; Kim KH; Hong HJ
Exp Mol Med; 2012 Apr; 44(4):293-302. PubMed ID: 22248567
[TBL] [Abstract][Full Text] [Related]
8. Nanocell targeting using engineered bispecific antibodies.
Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor.
Deng R; Bumbaca D; Pastuskovas CV; Boswell CA; West D; Cowan KJ; Chiu H; McBride J; Johnson C; Xin Y; Koeppen H; Leabman M; Iyer S
MAbs; 2016; 8(3):593-603. PubMed ID: 26918260
[TBL] [Abstract][Full Text] [Related]
11. Generation of affinity matured scFv antibodies against mouse neural cell adhesion molecule L1 by phage display.
Dong L; Chen S; Bartsch U; Schachner M
Biochem Biophys Res Commun; 2003 Jan; 301(1):60-70. PubMed ID: 12535641
[TBL] [Abstract][Full Text] [Related]
12. Development of a Theranostic Convergence Bioradiopharmaceutical for Immuno-PET Based Radioimmunotherapy of L1CAM in Cholangiocarcinoma Model.
Song IH; Jeong MS; Hong HJ; Shin JI; Park YS; Woo SK; Moon BS; Kim KI; Lee YJ; Kang JH; Lee TS
Clin Cancer Res; 2019 Oct; 25(20):6148-6159. PubMed ID: 31337646
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.
Zhang K; Geddie ML; Kohli N; Kornaga T; Kirpotin DB; Jiao Y; Rennard R; Drummond DC; Nielsen UB; Xu L; Lugovskoy AA
MAbs; 2015; 7(1):42-52. PubMed ID: 25484041
[TBL] [Abstract][Full Text] [Related]
14. An antibody against L1 cell adhesion molecule inhibits cardiotoxicity by regulating persistent DNA damage.
Nam JK; Kim AR; Choi SH; Kim JH; Choi KJ; Cho S; Lee JW; Cho HJ; Kwon YW; Cho J; Kim KS; Kim J; Lee HJ; Lee TS; Bae S; Hong HJ; Lee YJ
Nat Commun; 2021 Jun; 12(1):3279. PubMed ID: 34078883
[TBL] [Abstract][Full Text] [Related]
15. Single-chain variable fragment antibodies against the neural adhesion molecule CHL1 (close homolog of L1) enhance neurite outgrowth.
Dong L; Chen S; Richter M; Schachner M
J Neurosci Res; 2002 Aug; 69(4):437-47. PubMed ID: 12210838
[TBL] [Abstract][Full Text] [Related]
16. A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.
Orecchia P; Conte R; Balza E; Petretto A; Mauri P; Mingari MC; Carnemolla B
Eur J Cancer; 2013 May; 49(8):2022-33. PubMed ID: 23352437
[TBL] [Abstract][Full Text] [Related]
17. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.
Bedinger D; Lao L; Khan S; Lee S; Takeuchi T; Mirza AM
MAbs; 2016; 8(2):389-404. PubMed ID: 26563652
[TBL] [Abstract][Full Text] [Related]
19. Single chain Fv antibodies against neural cell adhesion molecule L1 trigger L1 functions in cultured neurons.
Dong L; Chen S; Schachner M
Mol Cell Neurosci; 2003 Feb; 22(2):234-47. PubMed ID: 12676533
[TBL] [Abstract][Full Text] [Related]
20. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
